Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

July 18, 2016

Primary Completion Date

November 20, 2017

Study Completion Date

November 20, 2017

Conditions
Acute Ischemic Stroke
Interventions
DRUG

natalizumab

Administered as specified in the treatment arm

DRUG

Placebo

Matched placebo

Trial Locations (53)

10032

Research Site, New York

17007

Research Site, Girona

19001

Research Site, Abington

19104

Research Site, Durham

Research Site, Philadelphia

20007

Research Site, Washington D.C.

20246

Research Site, Hamburg

27003

Research Site, Lugo

28007

Research Site, Madrid

28034

Research Site, Madrid

29010

Research Site, Málaga

29425

Research Site, Charleston

32429

Research Site, Minden

32611

Research Site, Gainesville

40225

Research Site, Düsseldorf

41013

Research Site, Seville

41017

Research Site, Seville

43210

Research Site, Columbus

46845

Research Site, Fort Wayne

47005

Research Site, Valladolid

48149

Research Site, Münster

51465

Research Site, Bergisch Gladbach

54292

Research Site, Trier

60528

Research Site, Frankfurt

63110

Research Site, St Louis

67063

Research Site, Ludwigshafen

68167

Research Site, Mannheim

69120

Research Site, Heidelberg

72076

Research Site, Tübingen

89081

Research Site, Ulm

90024

Research Site, Los Angeles

91054

Research Site, Erlangen

92103

Research Site, San Diego

95816

Research Site, Sacramento

96049

Research Site, Bamberg

97201

Research Site, Portland

97225

Research Site, Portland

97239

Research Site, Portland

97616

Research Site, Bad Neustadt/Saale

02114

Research Site, Boston

37920-6999

Research Site, Knoxville

04600

Research Site, Altenburg

01067

Research Site, Dresden

01307

Research Site, Dresden

04103

Research Site, Leipzig

02008

Research Site, Albacete

08916

Research Site, Badalona

08003

Research Site, Barcelona

08035

Research Site, Barcelona

SW17 0QT

Research Site, London

W6 8RF

Research Site, London

HA1 3UJ

Research Site, Harrow

ST4 6QG

Research Site, Stoke-on-Trent

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY